Clinical trials · New York, NY
Asthma clinical trials in New York
We’re tracking 25 recruiting asthma studies with a site in or near New York — including Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near New York
- NCT07052942RecruitingPhase 4
Asthma treatment personalization in primary care
This study tests whether adding a long-term, low-dose antibiotic (azithromycin) to your usual asthma treatment can help improve control and reduce attacks. It is for people whose asthma is still not well controlled despite using a daily inhaler.
New York, New YorkAges 13–75 - NCT06612294Recruiting
Asthma symptom perception study for older adults
This study looks at how older adults with asthma perceive their symptoms. It aims to improve understanding of asthma symptoms in people over 60 with uncontrolled asthma.
New York, New YorkAges 60 years+ - NCT05272241Recruiting
Asthma registry that helps researchers learn about asthma
This study enrolls people in specific cities to collect health information that helps researchers better understand asthma and how to recruit future studies. It may help by improving knowledge about asthma types and care in real-world settings.
New York, New YorkAges Any age - NCT07556159Recruiting
Asthma Disease Patterns and Outcomes in Everyday Care
This study observes how asthma is managed and controlled in routine clinical practice. Researchers will collect information about your asthma symptoms, treatments, and outcomes over time to better understand real-world asthma management.
New York, New YorkAges 6 years+ - NCT07116460Recruiting
Air filters for asthma in low-income housing
This study tests whether air filters placed in homes can reduce asthma symptoms in children and teens living in low-income housing in Northern Manhattan and the South Bronx. If you have asthma and are between 7 and 18 years old, you may be able to join.
New York, New YorkAges 7–18 - NCT07219173RecruitingPhase 2
Study of brenipatide for uncontrolled moderate to severe asthma
This study tests an investigational drug called brenipatide for people with moderate to severe asthma that isn't well controlled by current medicines. The purpose is to see if it can reduce asthma attacks better than a placebo (inactive treatment).
New York, New YorkAges 18–75 - NCT07359846RecruitingPhase 3
Study of GB-0895 for severe uncontrolled asthma in adults and teens
This trial tests an add-on treatment called GB-0895 for people with severe asthma that is not well controlled with current medications. It aims to see if adding this drug can reduce asthma attacks and improve lung function.
New York, New YorkAges 12–80 - NCT06136091Recruiting
Asthma study in select communities using a smartphone app
This study looks at how asthma affects people in certain communities and tests a new way to manage it using a smartphone app. It is for people with long-standing asthma and those without asthma, to compare their health over time.
New York, New YorkAges 6–17 - NCT06307665RecruitingPhase 3
Asthma study for teens comparing two inhalers
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
New York, New YorkAges 12–17 - NCT07582211Recruiting
BPAP breathing support for severe asthma attacks in children
This study tests whether a special breathing mask (BPAP) can help children ages 5–17 who come to the emergency room with severe asthma attacks. The mask gently pushes air into the lungs to help them breathe more easily.
New York, New YorkAges 5–17 - NCT06979323RecruitingPhase 3
Depemokimab study for asthma with imaging and bronchoscopy
This study tests depemokimab, an injectable biologic, to see how it works in the lungs of people with severe asthma. You would get the drug and have special imaging and a bronchoscopy (a tube with a camera placed into your airways to take tiny tissue samples) so doctors can understand how the medicine reduces inflammation.
New York, New YorkAges 18 years+ - NCT06664619RecruitingPhase 3
Study of a new combination inhaler for asthma
This study tests a new combination inhaler (fluticasone propionate and albuterol) for people with asthma age 12 and older. It helps see if this inhaler works better than a placebo in controlling asthma symptoms and preventing attacks.
Jersey City, New JerseyAges 12 years+ - NCT06750289RecruitingPhase 3
Testing benralizumab for uncontrolled eosinophilic asthma
This study tests if adding a new injectable medicine (benralizumab) to your current medium-dose inhaler works better than simply increasing your inhaler dose to control hard-to-treat asthma. It may help people with a specific type of asthma linked to high eosinophil levels.
Union City, New JerseyAges 12–75 - NCT06932263RecruitingPhase 2
Testing tozorakimab for uncontrolled asthma
This trial tests a new drug called tozorakimab for adults whose asthma is not well controlled despite using medium-to-high dose inhaled steroids. The study aims to find the best dose and see if it reduces asthma attacks.
Maspeth, New YorkAges 18–75 - NCT05341726Recruiting
Test a program to improve asthma control in Black adults
This study tests an approach that combines education and support to help adults with uncontrolled asthma manage their symptoms better and use treatments correctly. It focuses on Black adults receiving care at specific community health clinics.
Brooklyn, New YorkAges 18 years+ - NCT07276724RecruitingPhase 3
Study of GB-0895 for severe uncontrolled asthma
This trial tests an add-on medicine called GB-0895 for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve breathing.
The Bronx, New YorkAges 12–80 - NCT06935084Recruiting
Voice app for asthma management study
This study tests if a voice-controlled smartphone app (like Siri or Alexa) can help people with asthma manage their daily controller medicine better. You might be a good fit if you use a daily asthma inhaler and have a smartphone with a data plan.
The Bronx, New YorkAges 18 years+ - NCT07224061Recruiting
Asthma management program using technology and care coordination
This trial uses a smartphone app and care coordination to help children ages 4–12 with uncontrolled asthma. It aims to improve asthma control and reduce symptoms by connecting clinics and schools.
The Bronx, New YorkAges 4–12 - NCT07228052RecruitingPhase 4
Steroid shot to prevent return to the ER for asthma
This trial tests whether a single steroid shot given in the emergency department can help prevent your asthma symptoms from coming back and keep you from needing to return to the ER.
The Bronx, New YorkAges 18 years+ - NCT05757102RecruitingPhase 3
Test new inhaler combo versus standard inhaler in teens
This Phase 3 trial compares a triple inhaler (FF/UMEC/VI) against the usual double inhaler (FF/VI) to help control asthma symptoms and breathing tests in teens ages 12–17. It also checks how safe and tolerable the treatments are over the study period.
The Bronx, New YorkAges 12–17 - NCT07444567RecruitingPhase 3
Continuing benralizumab treatment after a previous study
This trial lets people who completed an earlier benralizumab study and are benefiting from the medicine keep receiving it. The goal is to provide ongoing access while we continue to monitor safety and effectiveness.
The Bronx, New YorkAges 6 years+ - NCT06691971Recruiting
Testing a device that detects wheezing in asthma attacks
This study is testing a device called AeviceMD that listens for wheezing—a whistling sound when breathing—to help doctors quickly spot asthma attacks. If you or your child is in the emergency room with a sudden asthma flare-up, you may be able to join.
The Bronx, New YorkAges 3 years+ - NCT06023589RecruitingPhase 3
Testing tezepelumab for kids with severe asthma
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
Staten Island, New YorkAges 5–11 - NCT06977581RecruitingPhase 2
study of PF-07275315 for moderate-to-severe asthma
This study tests a new medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It is for adults who have had asthma for at least a year, have had recent flare-ups needing steroids, and are not taking other biologic treatments.
Riverdale, New JerseyAges 18–70
Hear when a new Asthma trial opens near New York, NY
We’ll email you when one opens near New York, NY — at most once a week, no account needed, unsubscribe anytime.
Asthma trials in other cities
Where these studies are running near New York
Institutions with a site for the recruiting asthma studies listed above.
- Research Site · 5 studies
- Montefiore Medical Center · 3 studies
- Mount Sinai Health System · 3 studies
- Columbia University Irving Medical Center · 2 studies
- Columbia University Medical Center · 2 studies
- GSK Investigational Site · 2 studies
- Icahn School of Medicine at Mount Sinai · 2 studies
- Rutgers Robert Wood Johnson Medical School · 2 studies
What taking part in a asthma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting asthma studies in New York.
Common questions
- Are there asthma clinical trials near New York?
- Yes. We're currently tracking 25 recruiting asthma studies with a site near New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a asthma study near New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site near New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a asthma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New asthma studies open near New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.